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introduction: Solid malignancies at the foot and ankle region are rare and include
mainly soft-tissue sarcomas, bone sarcomas, and skin malignancies. Complete surgical 
resection with clear margins still remains the mainstay of therapy in these malignancies. 
However, attainment of negative surgical margins in patients with locally advanced
tumors of the foot and ankle region may require extensive surgery and could result in loss 
of extremity function. In these circumstances, plastic surgical techniques can frequently 
reduce functional impairment and cover soft-tissue defects, particularly in cases of large 
tumor size or localization adjacent to critical anatomic structures, thereby improving the 
quality of life for these patients. The aim of this article is to illustrate the various treatment 
options of plastic surgery in the multimodal therapy of patients with malignant tumors of 
the foot and ankle region.
Materials and methods: This article is based on the review of the current literature and 
the evaluation of the author’s own patient database.
Results: The local treatment of malignant extremity tumors has undergone major
changes over the last few decades. Primary amputations have been increasingly replaced 
by limb-sparing techniques, preserving extremity function as much as possible. Although 
defect coverage at the foot and ankle region is demanding due to complex anatomical 
features and functional requirements, several plastic surgical treatment options can be 
implemented in the curative treatment of patients with malignant solid tumors in this
area. Soft-tissue defects after tumor resection can be covered by a variety of local flaps. 
If local flaps are not applicable, free flap transfers, such as the anterolateral thigh flap,
parascapular flap, or latissimus dorsi flap, can be utilized to cover nearly all kinds of
defects in the foot and ankle region.
Conclusion: Soft-tissue reconstruction in the foot and ankle region is a vital component 
of limb-sparing surgery. It enables complete resection of locally advanced tumors and
subsequent adjuvant radiotherapy. Modern plastic surgical techniques should, therefore, 
be integrated in the multimodal treatment concept of malignancies in the foot and ankle 
region.
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TUMORS OF THe FOOT AND ANKLe 
ReGiON
Malignant neoplasms on the foot and ankle make up about 4% 
of all bone and soft-tissue tumors of the body (1–3). Soft-tissue 
sarcomas, as rare tumors of mesenchymal origin, account for 
about 1% of all adult malignancies but are located in the extremi-
ties in about 60% of all cases (4). Regarding the content of soft 
tissues, the lower extremities are affected more frequently than 
the upper extremities, with a ratio of 3:1. Other rare malignancies 
with localization at the foot are, for example, tumors of the skin, 
such as melanoma, and giant cell tumors of the tendon-sheath, 
vascular sarcomas, and carcinoma metastases. The local treat-
ment of soft-tissue sarcomas has undergone major changes over 
the last few decades. Primary amputations have been increasingly 
replaced by limb-sparing techniques, preserving extremity func-
tion as much as possible (3, 5). Interestingly, a recently published 
meta-analysis revealed that the width of negative surgical margins 
has no significant impact on overall survival (6). The data within 
the latter suggested that patients with clear margins had a better 
prognosis, but surgery to preserve functionality may result in very 
close margins without impairing survival. However, in patients 
with locally advanced soft-tissue sarcomas of the extremities, 
attainment of negative surgical margins may require extensive 
surgery and could result in a loss of extremity function. In these 
circumstances, plastic surgical techniques can frequently reduce 
functional impairment and cover soft-tissue defects, particularly 
in cases of large tumor size or localization adjacent to critical 
anatomic structures, thereby improving the quality of life for 
these patients. Whether limb preservation or ablative procedures 
are applied is also determined by the location of the tumor and 
the expectations and the functional demands of the patient.
ONCOLOGiCAL TReATMeNT STRATeGieS 
AND CONCePTS
Contemporary treatment strategies should include concepts of 
complete resection with negative surgical margins in combina-
tion with plastic reconstructive surgery, especially considering 
the postoperative functional aspects. The factors that determine 
the resectability of sarcomas are mainly the tumor size and 
localization. Regarding surgical resectability, the localization of 
the tumor is of great relevance. Deep or subfascial localization is 
associated with a higher risk of local recurrence or distant metas-
tasis when compared with superficial or epifascial localization 
(7–9). Regarding tumor size, large soft-tissue sarcomas are shown 
to have a diminished survival when compared with small tumors. 
However, large tumor size is found more frequently in high-grade 
tumors. Most survival studies have revealed that the tumor grade 
is the most significant prognostic factor (9, 10). Dedifferentiated 
and high tumor grade is also associated with higher invasiveness, 
resulting in extensive infiltration of the surrounding tissues.
In cases with extensive infiltration of functional structures, 
amputation still has to be considered as a treatment option in 
order to obtain clear margins (7, 11, 12). However, the fact that 
amputation as a curative treatment strategy for sarcomas in the 
extremities has no survival benefit when compared to limb-
preserving surgical procedures should be taken into account. 
It has been shown that amputation, especially in combination 
with radiotherapy, has no advantage compared to resection (6). 
The use of reconstructive surgery and adjuvant radiation since 
the 1980s has been able to reduce the amputation rate to less 
than 20% (13–16). The incidence of local recurrences under limb 
preservation therapy has decreased to 10–15% in recent years; 
however, no change in terms of overall survival has been shown 
(17, 18). Local control rates for high-grade tumors amounted 
to about 90% and to 90–100% for low-grade sarcomas. Notably, 
high-grade tumors are associated with a higher risk of local recur-
rence (19, 20). Subsequently, local recurrence has been found to 
be associated with a diminished survival when compared with 
the primary disease (7, 21, 22). Nowadays, primary indications 
for amputations are fortunately rare. Primary amputations are 
indicated when negative margins are not otherwise attainable. 
However, whenever an amputation is deemed necessary to 
obtain local control of an extremity soft-tissue sarcoma, isolated 
limb perfusion should be considered. Tumor necrosis factor 
alpha-based isolated limb perfusion has been demonstrated 
to result in a limb salvage rate of 81% in patients with locally 
advanced extremity soft-tissue sarcoma who would have oth-
erwise undergone amputation (23, 24). The second indication 
for primary amputation is the palliation of extensive ulcerative, 
bleeding, or odor-intensive tumors with complete loss of extrem-
ity function. A primary amputation must also be drawn early 
into consideration when satisfactory functional results cannot 
be expected from reconstructive techniques after extensive or 
disabling limb-sparing resections. In such cases, timely recov-
ery and mobilization might be achieved earlier after primary 
amputation.
PRiNCiPLeS OF TUMOR ReSeCTiON AT 
THe FOOT AND ANKLe
The implementation of a radical surgical procedure in the distal 
region of the limb is often difficult due to a limited soft-tissue 
situation. Attainment of clear margins becomes much more 
difficult in distal tumors and can result in soft-tissue defects. 
Plastic surgical techniques remain particularly indispensable in 
the treatment of such distal tumors. The extent of resection after 
histological confirmation depends on the size, grading, and local 
relationship to functional structures. Decisions regarding further 
leading reconstructive procedures also depend on it. Negative 
margins should be the goal of surgical therapy. Performance 
of the appropriate margins in soft-tissue sarcomas is often 
complicated by the extended growth of the tumor. Margins to 
adjacent functional structures should be taken into account in 
the oncosurgical considerations. These functional structures are 
fascia, synovia, periosteum, and perivascular and perineural tis-
sue. When there is tumor infiltration of such structures, en-block 
resection should be performed. The course of vascular structures 
should be taken into account during the resection to allow plan-
ning of reconstructive procedures by using pedicled or free tissue 
transplantation.
March 2016 | Volume 3 | Article 153
Ring et al. Reconstruction of Foot Defects after Tumor Resection
Frontiers in Surgery | www.frontiersin.org
ANATOMiCAL AND SURGiCAL FeATUReS
Whereas limb salvage has become the standard of care in the 
treatment of tumor in an extremity, the unique anatomy of the 
foot presents challenges in reconstructing a viable and functional 
limb. The defect coverage in the area of the foot and ankle region 
is demanding due to complex anatomical features and functional 
requirements. The skeletal stability of the foot and ankle region, 
the resilience of the soft tissues, and the preservation of sensa-
tion are at the forefront of reconstructive considerations. Here, 
profound knowledge of the anatomy of the foot and ankle area is 
essential for the development of a rational treatment algorithm 
for covering soft-tissue defects. Hidalgo and Shaw studied the 
arterial anatomy and the cutaneous nerve supply of the plantar 
skin extensively in the 1980s, providing guidelines of safe plantar 
incisions and flap design (25, 26). Prior to their work, flap designs 
on the plantar aspect of the foot were based on the concept that 
blood supply proceeds from the deep to the superficial tissue. 
Therefore, plantar flaps were usually raised subfascially requiring 
extensive dissection of the plantar soft tissue and, thus, resulting 
in severe foot and donor site morbidities (27). However, Hidalgo 
and Shaw demonstrated that local flaps at the plantar aspect could 
be designed with preserved sensitivity and abundant blood sup-
ply as reliable and safe alternatives without the need of subfascial 
dissection. Based on their findings, they further divided the foot 
into four major areas based on different requirements for recon-
struction and the types of flaps available (28, 29). These are the 
proximal and distal weight-bearing plantar areas, the dorsum and 
the ankle region including the malleoli, the Achilles tendon, and 
the non-weight-bearing heel area. Furthermore, they provided a 
classification of foot defects and an algorithm of their coverage 
whose principles are still relevant. They preferred to cover soft-
tissue losses less than 3  cm2 with local flaps in weight-bearing 
areas and with skin grafts in non-weight-bearing areas (Type I). 
Local flaps are more durable than skin grafts and allow normal 
weight-bearing on the reconstructed surface. Plain local flaps, 
such as V-Y flaps and transposition flaps, should be preferred to 
avoid a soft-tissue surplus, which could enhance strains on the 
scar at walking and, thus, increasing the risk of ulceration. Skin 
grafting represents a simple and safe procedure to cover small 
defects with a well-vascularized wound bed. However, skin grafts 
are usually suitable for smaller defects at the dorsum and non-
weight-bearing areas at the instep but are fragile and can generate 
painful scars and ulcerations when transplanted on tenuous soft 
tissue. Therefore, Hidalgo and Shaw do not recommend skin 
grafting alone for larger defects. Such Type II defects, which are 
defined to be larger than 3 cm2 without bone involvement were 
preferred to be covered by free fasciocutaneous, free muscu-
locutaneous flaps, or local flaps to ensure a durable soft-tissue 
coverage preventing recurrent ulcerations, improving the scar 
qualities, and reducing strains on the scars. Large tissue losses 
with bone involvement (Type III) were recommended to be 
reconstructed with free flaps or free osteocutaneous transfers if 
necessary. Here, adequate soft-tissue coverage also provides an 
essential base for following necessary surgical bone procedures. 
Bulky soft-tissue surpluses can be thinned out easily in future 
procedures after healing.
The reconstruction of the highly specific, thick, load-capable, 
and stress-resistant skin of the weight-bearing proximal and 
distal plantar area is more difficult, because the patient’s own 
tissue from other donor regions of the body does not often meet 
the requirements with regard to tissue quality and functional 
needs. By contrast, soft-tissue coverage of the dorsum of the foot 
and the ankle region is of thin and pliable skin with a delicate 
subcutaneous adipose tissue layer. This feature is often severe 
in surgical interventions, for example, in osteosynthetic care of 
ankle fractures. In this case, due to the peculiarity of the soft-
tissue cover, wound complications with exposure of structures, 
such as tendons, joint capsule, bone, and hardware, can occur. 
Furthermore, the mobility of the soft tissue covering the foot 
and ankle is due to quite limited multiple zones of adherence. 
Consequently, defects in serving areas can rarely be treated by 
local tissue displacement. In such cases, tissue from other parts 
of the body must be free transplanted. However, the tissue units 
used for microvascularized transfer are often bulky and have to 
be thinned out and adapted in the course of correction operations 
for subsequent shoe care and esthetic perception. Furthermore, 
the fact that the free transplanted tissue is not innervated must 
be considered. This fact may stimulate the formation of pressure 
ulcers. The reconstruction of complex defects of the foot has expe-
rienced a steady improvement in recent decades. Achievements 
in the therapy have been kept particularly for innovative surgical 
techniques and a better understanding of the specific tissue situa-
tion and functional requirements of the foot and ankle area.
PLASTiC SURGiCAL ReCONSTRUCTiON 
OPTiONS
Tumor removal is often accompanied by major tissue defects. 
Furthermore, there might be an exposure of functional structures, 
such as bones, tendons, nerves, and blood vessels. Therefore, 
plastic surgical reconstruction methods must be an integral part 
of oncosurgical treatment concepts. Moreover, transfer of healthy 
tissue with adequate blood supply enables adjuvant radiation and 
chemotherapy, and might improve the effectiveness by improving 
oxygen nourishment in the tumor bed. A simple reconstructive 
procedure, such as skin grafting, is, therefore, not usual, since 
the resulting soft-tissue coverage is often insufficient for adjuvant 
radiotherapy. However, the reconstructive ladder should still be 
addressed when considering soft-tissue coverage at the foot and 
ankle area. Some local flaps have proven to be very efficacious 
in the treatment of foot and ankle defects. Small defects at the 
non-weight-bearing sole can be covered by simple cutaneous or 
myocutaneous V-Y flaps. Due to its reliable vascular supply, its 
proportions and the moderate donor site defect, the distally based 
sural flap has proven itself in the coverage of smaller defects at the 
hind foot and malleolar region (30–33). The dominant pedicle 
of the distally based sural artery flap is a branch arising from 
the popliteal artery descending from the popliteal fossa between 
the heads of the gastrocnemius muscle. It is accompanied by the 
medial sural cutaneous nerve from the tibial nerve and small 
venae comitantes. The sural artery flap is a fasciocutaneous flap 
located at the proximal dorsal area of the lower leg. Elevation of 
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the flap proceeds proximally after visualization of the entrance 
of the dominant pedicle into the deep fascia in a subfascial plane 
until an adequate arc of rotation is achieved. Notably, the pivot 
point of the pedicle should be at least 5 cm proximal of the lateral 
malleolus in order to preserve the anastomoses with the peroneal 
artery. The maximum size of the distally based sural flap is limited 
because of its slight perfusion provided by the arterial network 
surrounding the sensory medial sural cutaneous nerve. Delayed 
distally based sural flaps can be raised larger and present an 
improved reliability but require a two-step surgical approach (34). 
Such delayed reverse sural flaps are particularly suited for small 
hind foot defects (35, 36). However, defects at the weight-bearing 
hind foot should ideally be reconstructed with sensible local flaps 
to avoid ulcerations. Mendieta et al. reported a case of a heel defect 
in which they connected the severed nerve end of a distally based 
sural flap with the intermediate dorsal cutaneous branch of the 
superficial peroneal nerve to give sensibility to the flap (37). Tan 
et al. recently reported a case series of such neurotized distally 
based sural flaps in 14 patients where all flaps survived and two-
point discrimination achieved at least 14 mm after 6 months (38). 
The neurotized sural flap represents an interesting modification 
for the sensory reconstruction of weight-bearing hind foot defects 
and upcoming studies deserve attention. In the armamentarium 
of local flaps, the instep-island flap based on the medial plantar 
neurovascular pedicle provides another option for the sensory 
soft-tissue reconstruction of small hind foot defects (39, 40). The 
instep-island flap occupies the skin of the non-weight-bearing 
instep between the first metatarsal head and the distal portion 
of the heel. The flap is elevated distally deep to the plantar fasica 
and dissection continues proximally toward the medial plantar 
artery and nerve. Here, the medial plantar nerve can be split from 
distal to proximal in order to preserve the sensitivity of the flap 
and the medial foot (41, 42). The instep-island flap is suited for 
smaller defects, and the donor site must usually be transplanted 
with a skin graft.
If local flaps are not applicable for soft-tissue coverage, free 
tissue transfers can be utilized. Following the resection of a 
malignant tumor in the foot, the use of microvascularized tissue 
has been proven to be a successful surgical technique, offering 
an alternative to ablative surgery with functional restoration of 
the salvaged limb. Large defects of the foot can be treated by free 
microvascular myocutaneous or fasciocutaneous tissue transfer. 
If small defects, exposing bones or tendons, are not eligible for 
local flaps, small free microvascular flaps can be applied. These 
flaps cause a very low donor site morbidity. Myocutaneous and 
fasciocutaneous flaps have the advantage of replacing the missing 
tissue volume. Osseous surfaces can also be adequately covered 
and padded. If local flaps are not available, the implementation 
of a free tissue transfer should be taken into consideration. Such 
flaps provide adequate soft-tissue coverage for adjuvant radiation. 
A new group of propeller perforator flaps based on perforators 
from the anterior and posterior tibial artery and from the pero-
neal artery has been established in recent years, which also allows 
good defect management. In the Tokyo consensus, a propeller 
flap is defined as an island flap that reaches the recipient site 
through an axial rotation. The classification is based on the nour-
ishing pedicle (subcutaneous pedicled propeller flap, perforator 
pedicled propeller flap, and supercharged propeller flap), the 
degrees of skin island rotation (from 90 to 180°), and, when pos-
sible, the artery of origin of the perforator (43, 44). Dong et al. 
recently reported a series of 20 patients with soft-tissue defects of 
the lower leg and foot that were covered by perforator pedicled 
propeller flaps (45). All flaps survived and the areas of soft-tissue 
defect ranged from 2 cm × 8cm to 10 cm × 20 cm. The donor 
sites could be closed primarily in 12 patients and skin grafted 
in 8 patients. Georgescu et al. reported another retrospectively 
analyzed series using perforator pedicled propeller flaps in 24 
diabetic patients with acute and chronic wounds at the foot (46). 
A primary healing rate (96%) was obtained in 72% of all cases, 
whereas flap necrosis occurred in 24% and complete flap loss in 
4%. Specific data after oncological resection and adjuvant therapy 
are still missing to date, but in experienced hands and in well 
selected cases, propeller perforator flaps can cover defects at the 
foot and ankle region reliably and provide an alternative to free 
flaps. In our experience, plastic reconstructive procedures after 
tumor resection in the foot and ankle area are required in about 
50% of cases and are associated with a high success rate. Free 
transplants, such as fasciocutaneous flaps from the anterolateral 
thigh (ALT) and parascapular region, and also myocutaneous 
flaps, such as latissimus flap with or without a skin island, domi-
nate. The ALT flap represents a versatile fasciocutaneous flap and 
is located at the anterolateral surface of the thigh (Figures  1 
and 2). Its dominant pedicle proceeds from the septocutaneous 
or myocutaneous perforators of the descending branch of the 
lateral circumflex femoral artery. Primary closure of the donor 
site is usually possible when the flap width is 10 cm or less. Larger 
flaps need skin grafting of the donor site. Depending on the dis-
tribution of the subcutaneous fat in corpulent patients, the ALT 
flap might be less bulky than the parascapular flap in some cases 
and, thus, should be preferred in the soft-tissue reconstruction 
of the foot. The parascapular flap is a fasciocutaneous flap of the 
posterior trunk and is nourished by the descending branch of 
the circumflex scapular artery, which emerges from the triangular 
space between teres major, teres minor, and the long head of the 
triceps brachii muscle (Figures 3 and 4). The parascapular flap 
can be harvested up to 12 cm in width and 25 cm in length with 
primary closure. Similar to the parascapular flap, the latissimus 
dorsi muscle flap is also one of the most versatile flaps available 
to soft-tissue reconstruction (Figure 5). The expendable muscle 
with its reliable pedicle (thoracodorsal artery) can be harvested 
with or without a skin island from the posterior trunk and is 
excellently suited for widespread defects. The donor site morbid-
ity of most free flaps is moderate and well tolerated by most of 
the patients, especially if the donor site can be closed primarily 
(47–49). Despite the adjuvant radiotherapy applied, the postop-
erative complications are tolerable and do not limit the use of 
microvascular tissue transfer.
As a reconstructive option after tumor resection, local flaps 
represent a reliable tool and can cover a wide range of smaller 
defects. Nevertheless, concerns over distant iatrogenic implanta-
tion of tumor cells at the donor site of local flaps exist when tumor 
resection and flap coverage were performed in the same surgical 
procedure. Reviewing the literature, there has, unfortunately, 
been no systematic analysis on this issue. However, iatrogenic 
FiGURe 2 | A 62-year-old male presented with first diagnosis of a 
myxoid fibrosacoma G2 at the dorsum of his right foot (A). After 
oncological tumor resection, the defect was reconstructed with a free 
fasciocutaneous ALT flap from the thigh (B,C).
FiGURe 1 | A 77-year-old female was presented after incomplete 
resection of a liposarcoma G2 on the lateral ankle of her right foot.  
The initial tumor localization is shown by MRI image (A). A two-stage 
reconstruction of the defect after extensive resection (B) was done by free 
transplantation of an adipocutaneous flap (C) from the anterolateral region of 
the thigh (ALT flap).
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tumor metastases at donor tissue sites after local flap reconstruc-
tion are a rare occurrence and should not preclude the use of 
local flap reconstruction (50). They have been described only 
in selected case reports (51). Furthermore, the effect of donor 
site radiation on the incidence of iatrogenic tumor metastases 
FiGURe 4 | A 54-year-old male with infiltrative myxoid fibrosarcoma G2 of the Achilles’ tendon of his left leg and R2 status after foreign surgery (A). 
Reconstructive procedure after oncological resection was performed by use of a free parascapular flap (B).
FiGURe 3 | A 49-year-old male with a clear cell sarcoma G2 localized on his right foot (A). The patient was transferred to our department for oncological 
resection and plastic reconstruction after an incomplete tumor resection. The coverage of the soft-tissue defect about the load-exposed part of the sole was 
performed by a free fasciocutaneous flap (B,C) from the parascapular area.
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FiGURe 5 | A 46-year-old female with soft-tissue defect on her left foot after tumor resection (A). The reconstruction was carried out by free 
transplantation of a latissimus dorsi muscle with split skin (A,B). Image of the foot after healing (C).
still remains unclear and should be examined (50). Beside the 
aforementioned concerns, local flaps can offer some slight but 
noteworthy advantages. In contrast to free flaps, local flaps do not 
require intensive postoperative flap inspections. Postoperative 
positioning protocols and anticoagulation regimens are less 
stringent. However, there has been a paradigm shift in the last 
few decades. Free tissue transfers can be performed with the same 
or even higher degree of safety than local flap transfer as a result 
of the improvements in microsurgical techniques nowadays. 
Safe dissection and positioning of a local flap at the hind foot 
can be technically more demanding, risky, and time-consuming 
when compared to a free flap transfer in a two-team approach. 
Due to the microsurgical and anesthesiological improvements, 
free flap transfers have become physically less demanding 
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surgical procedures and have also become suitable for patients 
with  vascular comorbidities.
Unfortunately, not all postoperative wound complications can 
be anticipated. For defects that extend to the tendons or joints, 
flap reconstruction is always required for adequate closure. A 
forced wound closure and “unexpected” wound complications 
can be slow to heal, devastating for the patient, and delay adjuvant 
radiotherapy. In this instance, early referral to a plastic surgeon 
is necessary in these cases to prevent devitalized superficial 
tissue from becoming infected and generating a deep infection 
that involves tendon, bone, or hardware. The use of free tissue 
transfer remains at the highest level on the reconstructive ladder. 
Although it is more complex, free tissue transfer may be necessary 
as a first choice. Our experience indicates that microvascularized 
tissue transfer is often the most suitable first option in accordance 
with established reconstructive principles. Furthermore, wound 
complications can occur more often after adjuvant radiation. 
Although defects, at first appearance, may be closed primarily 
or by using simple methods, such as split-thickness skin grafts, 
one must take the possibility of postoperative and postradiogenic 
wound complication into consideration. In those cases where 
there is an increased risk of exposure of tendons, bones or osteo-
synthetic material, a prophylactic use of an effective free flap for 
reconstruction should be considered. In the presence of avascular 
scar tissue, it should be removed before reconstruction. The use 
of prophylactic flaps in foot and ankle reconstruction is of great 
interest in patients with a high risk of wound healing disorders.
In addition to transplantation of tissue to cover the defects, 
the replacement of functional structures, such as tendons, ves-
sels, and nerves, are at the forefront. Common peroneal nerve 
lesions or extensive loss of the anterior tibialis muscle might be 
an inevitable part of oncological resection and lead to a drop foot 
deformity. Primary transfer of the posterior tibialis tendon to the 
anterior tibialis tendon can restore the active extension of the 
foot (52, 53). There have been several technical modifications of 
FiGURe 6 | Treatment algorithm for soft-tissue reconstructions at the foot after oncological resection.
this procedure to date and most of them improve the extremity 
function notably (54, 55). Indications for the oncological resec-
tion of the tibial or peroneal nerve are fortunately rare, but, if 
necessary, nerve grafting using the sural nerve can restore some 
protective touch sensibility at the plantar foot even after nerve 
defects of several centimeters (56, 57). However, there are still 
controversies about the timing of nerve grafting, especially 
when adjuvant radiation treatment is planned. There are miss-
ing specific data for peroneal and tibial nerve reconstructions 
to date, but a very recent study that analyzed the functional 
outcome of multiple sural nerve grafts for facial nerve defects 
after oncological resection could not detect any adverse effects of 
adjuvant radiation treatment on the outcome of the nerve grafts 
and endorsed an immediate nerve grafting after primary tumor 
resection (58).
CONCLUSiON
Surgical therapy provides the basis for local tumor control in soft-
tissue sarcoma. The goal defined is the resection of the tumor 
with clear surgical margins, followed by adjuvant radiotherapy 
in highly malignant tumors. In many cases, more complex plastic 
surgical reconstructions, such as the replacement of nerves, blood 
vessels, and bone, or transfer of muscles or tendons, are required 
due to the close proximity to functionally relevant anatomical 
structures. Defects can be covered by means of plastic surgery 
techniques so that the foremost unresectable tumors become 
 curable. In our institution, we use the treatment algorithm 
depicted in Figure 6 in order to cover most of the defects resulting 
after tumor resection.
At the present time, due to efforts in reconstructive plastic 
surgery, complex tumor resection with clear margins can be 
performed while still preserving the function that once may 
have been considered unsalvageable, particularly in the case of 
advanced tumors.
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